This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
- CNIO team explains lower cancer incidence rate in patients experiencing brain and nervous system diseases
20.02.2014
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer’s disease, which can reduce the risk of suffering from cancer by up to 50%. Various theories have been put forward in an attempt to explain this relationship between diseases that […] - A CNIO study finds a ‘molecular scaffolding’ that maintains skin structure and organisation
16.01.2014
The human body is daily exposed to external assaults such as bacteria, ultraviolet light or chemical agents. Skin, the largest organ of the body, is the first line of defense against these agents. Skin performs this function thanks to the close connections established between its cells (e.g. adherens junctions). The loss of cell adhesion between […] - Seve Ballesteros Foundation visits CNIO
20.12.2013
Carmen Ballesteros, daughter of the legendary golfer Severiano Ballesteros, visited the Spanish National Cancer Research Centre (CNIO) yesterday, on behalf of the Seve Ballesteros Foundation and donated a cheque for 100,000 euros. CNIO will destine this amount to support brain tumour research in the laboratory of Massimo Squatrito, Head of the Seve-Ballesteros Foundation Brain Toumour […] - CNIO and Merck sign license agreement for the development of new cancer drugs
18.12.2013
The Spanish National Cancer Research Centre (CNIO) and the German chemical and pharmaceutical company Merck today signed an agreement in Madrid to collaborate in the area of cancer drug development. This global option and license agreement will encourage the development and commercialisation of new compounds in the field of oncology.With this agreement, the CNIO has […] - CNIO study chosen as Discovery of the Year in regenerative medicine
11.12.2013
The prestigious journal Nature Medicine has taken a look at the year and chosen one of the Spanish National Cancer Research Centre’s (CNIO) studies as the most important one in the category of stem cells research. The special December edition of Nature Medicine selects the most notable advance in eight areas of research, which, together […] - Maria Blasco named fellow of Royal National Academy of Pharmacy
09.12.2013
Maria Blasco, the Director of the Spanish National Cancer Research Centre (CNIO), took possession last Thursday (December 5) of her post as a Corresponding Fellow of the Spanish Royal Academy of Pharmacy (RANF). The ceremony— which took place at RANF headquarters— was chaired by Maria Cascales Angosto, one of the academy’s Permanent Members. During the […] - CNIO team turns tumour suppressor into anti-cancer target
04.12.2013
The laboratory of Marcos Malumbres, who is head of the Spanish National Cancer Research Centre’s (CNIO) Cell Division & Cancer Group, working alongside Isabel Fariñas’ team from the University of Valencia, shows, in a study published today in the journal Nature Communications, how in mice the elimination of the Cdh1 protein—a sub-unit of the APC/C […] - Four years of clinical trials at the CNIO
02.12.2013
Madrid (Spain), December 2, 2013.Four years ago, the Spanish National Cancer Research Centre (CNIO) embarked on a new quest with the creation of its Clinical Research Programme. This Programme was financed in part with a 12 million euro credit loan from the Ministry of Health, which was distributed between 2009 and 2011. The goal of […] - CNIO scientists create the first large catalogue of interactions between drugs and proteins
28.11.2013
The three-dimensional structures of proteins determine how, when and where they bind to drugs and other compounds. In 2012 alone, thousands of structures like this were resolved. Now this mass of information needs to be translated into a biological context that can be used to extract relevant functions from these interactions, as well as significant […]